Related Experiment Video
Updated: May 28, 2026
09:55
Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
Equity, Diversity, Inclusion and Accessibility in Pharmacy Education: A Scoping Review
Mirey Alfarah1,2, Ivy Kan3, Marie A Vander Kloet4
1Centre for Pharmacy, Department of Global Public Health and Primary Care, University of Bergen, 5009 Bergen, Norway.
Pharmacy (Basel, Switzerland)
|May 27, 2026
Summary
Integrating equity, diversity, inclusion, and accessibility (EDIA) in pharmacy education is crucial but fragmented. Faculty development, curriculum, and teaching strategies need a more comprehensive, program-level approach for diverse populations.
Area of Science:
- Pharmacy Education
- Health Professions Education
- Social Determinants of Health
Background:
- Preparing pharmacists for diverse populations necessitates integrating equity, diversity, inclusion, and accessibility (EDIA).
- Current integration of EDIA in pharmacy education is uneven and not well understood.
- Addressing EDIA is vital for equitable healthcare delivery and patient outcomes.
Purpose of the Study:
- To conduct a scoping review examining the integration of EDIA in pharmacy education.
- To analyze how EDIA is addressed across faculty development, curriculum content, and teaching strategies.
- To identify gaps and areas for improvement in EDIA implementation in pharmacy programs.
Main Methods:
- Scoping review following Joanna Briggs Institute guidance.
- Searched six databases (Embase, Medline, APA PsycINFO, CINAHL, ERIC, Web of Science) for studies from 2014-2025.
- Screened 3031 records, including 86 studies.
Main Results:
- Most studies focused on curriculum (48/86) and teaching strategies (35/86), with minimal focus on faculty development (3/86).
- Research predominantly from the USA, using survey methods; limited global representation.
- EDIA topics often isolated, emphasizing intercultural communication, with gaps in disability, migration, and socioeconomic status; intersectional approaches were rare.
Conclusions:
- EDIA integration in pharmacy education is fragmented, often standalone rather than systemic.
- Significant gaps exist in faculty development, methodological diversity, and global scope.
- Need for sustained, program-level EDIA integration and strengthened faculty development initiatives.
Related Concept Videos
01:26Equity Theory
Equity theory explains how our sense of fairness influences the dynamics of close relationships. Rooted in social psychology, the theory posits that individuals evaluate fairness by comparing the ratio of their contributions to the rewards they receive. Relationship satisfaction is highest when these ratios are perceived as balanced between partners, promoting mutual reciprocity and a sense of justice.Equity vs. Equality in RelationshipsEquity is distinct from equality. Fairness does not...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:16Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...